University Of Maryland, Baltimore

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1807-01-01

Employees: 7.3K

Market Cap: -

Website: http://www.umaryland.edu

Clinical Trials

Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by Surgery

Phase 2

Terminated

Conditions: Triple-negative Breast Cancer
HER2-negative Breast Cancer
Stage I Breast Cancer
Stage IIIA Breast Cancer
Estrogen Receptor-negative Breast Cancer
Progesterone Receptor-negative Breast Cancer
Stage II Breast Cancer

Interventions: Drug: entinostat
Drug: anastrozole
Other: diagnostic laboratory biomarker analysis
Procedure: therapeutic conventional surgery

First Posted Date: 2010-11-04

Last Posted Date: 2022-05-03

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 5

Registration Number: NCT01234532

Locations: 🇺🇸
University of Maryland Baltimore, Baltimore, Maryland, United States

Nicotinic Modulation of the Default Network

Not Applicable

Completed

Conditions: Magnetic Resonance Imaging
Cognition
Nicotine
Mecamylamine

Interventions: Drug: Placebo
Drug: Nicotine
Drug: Mecamylamine

First Posted Date: 2010-10-19

Last Posted Date: 2019-08-19

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 21

Registration Number: NCT01223404

Locations: 🇺🇸
National Institute on Drug Abuse, Intramural Research Program, Baltimore, Maryland, United States
🇺🇸
Maryland Psychiatric Research Center, Baltimore, Maryland, United States

Integrative Meditation (IM) for Cocaine Addiction

Not Applicable

Completed

Conditions: Cocaine Addiction

Interventions: Behavioral: Supportive Counseling
Behavioral: Integrative Meditation

First Posted Date: 2010-09-29

Last Posted Date: 2022-03-14

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 66

Registration Number: NCT01211418

Locations: 🇺🇸
Alcohol and Drug Abuse Program (ADAP), Baltimore, Maryland, United States
🇺🇸
Outpatient Addiction Treatment Service (OATS), Baltimore, Maryland, United States
🇺🇸
University of Maryland Methadone Treatment Program, Baltimore, Maryland, United States

R5 Integrase Study in HIV-1 Naive Patients

Not Applicable

Completed

Conditions: HIV Infections

Interventions: Drug: Raltegravir and Maraviroc in combination

First Posted Date: 2010-09-17

Last Posted Date: 2022-11-14

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 7

Registration Number: NCT01204905

Locations: 🇺🇸
University of Maryland, Institute of Human Virology, Baltimore, Maryland, United States

Imaging of Traumatic Brain Injury

Completed

Conditions: Traumatic Brain Injury

First Posted Date: 2010-09-08

Last Posted Date: 2022-07-21

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 150

Registration Number: NCT01196299

Locations: 🇺🇸
University of Maryland Medical Center, Baltimore, Maryland, United States

Salsalate for Insulin Resistance in Schizophrenia

Not Applicable

Completed

Conditions: Insulin Resistance
Schizophrenia

Interventions: Drug: salsalate

First Posted Date: 2010-08-17

Last Posted Date: 2022-03-11

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 13

Registration Number: NCT01182727

Locations: 🇺🇸
Baltimore VA Medical Center, Baltimore, Maryland, United States
🇺🇸
Maryland Psychiatric Research Center, Baltimore, Maryland, United States

Face Transplantation

Not Applicable

Completed

Conditions: Transplantation: Facial Transplantation

Interventions: Procedure: Face Transplant

First Posted Date: 2010-06-09

Last Posted Date: 2021-09-30

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 1

Registration Number: NCT01140087

Locations: 🇺🇸
University of Maryland, Baltimore, Baltimore, Maryland, United States

Pharmacogenomics of Thiazolidinediones

Not Applicable

Completed

Conditions: Type 2 Diabetes

Interventions: Drug: Pioglitazone

First Posted Date: 2010-06-02

Last Posted Date: 2024-03-15

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 114

Registration Number: NCT01135394

Locations: 🇺🇸
University of Maryland School of Medicine, Baltimore, Maryland, United States

Safety and Immunogenicity of CVD 1902 Oral Attenuated Vaccine to Prevent S. Paratyphi A Infection

Phase 1

Completed

Conditions: Salmonella

Interventions: Other: Placebo
Biological: CVD 1902, a Salmonella enterica Serovar Paratyphi A live, oral vaccine

First Posted Date: 2010-05-24

Last Posted Date: 2021-04-30

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 51

Registration Number: NCT01129453

Locations: 🇺🇸
Shin Nippon Biomedical Laboratories (SNBL) Inpatient Facility, Baltimore, Maryland, United States
🇺🇸
University of Maryland, Baltimore Center for Vaccine Development, Baltimore, Maryland, United States

Long-term Follow-up of Spare the Nephron (STN) Patients

Completed

Conditions: Kidney Transplant

First Posted Date: 2010-05-19

Last Posted Date: 2022-05-02

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 128

Registration Number: NCT01126333

Locations: 🇺🇸
University of Maryland Medicine, Division of Adult Nephrology, Baltimore, Maryland, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy